{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:54:34Z","timestamp":1775001274867,"version":"3.50.1"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"3b","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:p>PURPOSE: To report the clinical and neuroimaging, central nervous system (CNS) findings of patients with Fabry disease (FD) during 24 months of enzyme replacement therapy (ERT) with agalsidase-alpha. METHOD: Eight patients were included. Six completed 24 months of ERT. Clinical and magnetic resonance imaging (MRI) data were obtained at 0, 12 and 24 months of ERT. White matter lesions (WML) were evaluated as well as their relation to age, symptoms and neurological examination (CNS score). RESULTS: MRI was stable in 3 patients. WML and CNS score worsened in one patient, fluctuated in another, and improved in the sixth patient. In the whole series, there were 15 WML at baseline, and 19 at the 24th month. In two years, 4 lesions disappeared, whereas 8 appeared. CONCLUSION: A widespread pattern of silent WML in FD was seen. In two years, some WML appeared, and some disappeared. If these phenomena were related to the natural history, remains to be demonstrated.<\/jats:p>","DOI":"10.1590\/s0004-282x2006000500002","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T14:42:52Z","timestamp":1161268972000},"page":"711-717","source":"Crossref","is-referenced-by-count":33,"title":["White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up"],"prefix":"10.1590","volume":"64","author":[{"given":"Laura B.","family":"Jardim","sequence":"first","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio","family":"Aesse","sequence":"additional","affiliation":[{"name":"Hospital Moinhos de Vento, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo M.","family":"Vedolin","sequence":"additional","affiliation":[{"name":"Hospital M\u00e3e de Deus, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udio","family":"Pitta-Pinheiro","sequence":"additional","affiliation":[{"name":"Hospital Moinhos de Vento, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Marconato","sequence":"additional","affiliation":[{"name":"Hospital Moinhos de Vento, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira G.","family":"Burin","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Cecchin","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina B.O.","family":"Netto","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula S.","family":"Matte","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Pereira","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciane","family":"Kalakun","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"The metabolic bases of inherited disease","first-page":"3733","volume-title":"Alpha-galactosidase A deficientcy: Fabry disease","author":"Desnick RJ","year":"2001","edition":"8"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","article-title":"Quantitative analysis of cerebral vasculopathy in patients with Fabry disease","volume":"50","author":"Crutchfield KE","year":"1998","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme repalcement therapy","volume":"104","author":"Moore DF","year":"2001","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1097\/01.ASN.0000015239.57436.18","article-title":"Anderson-Fabry disease: extrarenal, neurologic manifestations","volume":"13","author":"Kolodny EH","year":"2002","journal-title":"J Am Soc Nephrol","ISSN":"https:\/\/id.crossref.org\/issn\/1046-6673","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease. A randomised controlled trial","volume":"285","author":"Schiffman R","year":"2001","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng C","year":"2001","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"for International Fabry Disease Study Group: Long term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox WR","year":"2004","journal-title":"Am J Hum Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9297","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck M","year":"2004","journal-title":"Eur J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2972","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","article-title":"CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy","volume":"27","author":"Jardim L","year":"2004","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<420::AID-AJMG6>3.0.CO;2-Z","article-title":"Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG)","volume":"84","author":"Ashton-Prolla P","year":"1999","journal-title":"Am J Med Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0148-7299","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry\u00b4s disease","volume":"40","author":"Mitsias P","year":"1996","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"Moore DF","year":"2003","journal-title":"Brain Res Bull","ISSN":"https:\/\/id.crossref.org\/issn\/0361-9230","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410230513","article-title":"Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation","volume":"23","author":"Kaye EM","year":"1988","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-2-4","article-title":"Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease","volume":"2","author":"Moore DF","year":"2002","journal-title":"BMC Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore DF","year":"2002","journal-title":"Stroke","ISSN":"https:\/\/id.crossref.org\/issn\/0039-2499","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jmri.20162","article-title":"Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study","volume":"20","author":"Moore DF","year":"2004","journal-title":"J Magn Reson Imaging","ISSN":"https:\/\/id.crossref.org\/issn\/1053-1807","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot KD","year":"2001","journal-title":"J Med Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0022-2593","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females (letter)","volume":"38","author":"MacDermot KD","year":"2001","journal-title":"J Med Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0022-2593","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1023\/A:1012499119196","article-title":"Natural history of Fabry disease in males: preliminary observations","author":"Schiffmann R","year":"2001","journal-title":"J Inherit Metab Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0141-8955","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.STR.17.6.1084","article-title":"Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors","volume":"17","author":"Awad IA","year":"1986","journal-title":"Stroke","ISSN":"https:\/\/id.crossref.org\/issn\/0039-2499","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1227\/00006123-198702000-00004","article-title":"Incidental lesions noted on magnetic resonance imaging of the brain: prevalence and clinical significance in various age groups","volume":"20","author":"Awad IA","year":"1987","journal-title":"Neurosurgery","ISSN":"https:\/\/id.crossref.org\/issn\/0148-396X","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v64n3b\/31606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T22:49:40Z","timestamp":1555886980000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2006000500002&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":21,"journal-issue":{"issue":"3b","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0004-282X2006000500002"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2006000500002","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}